MENU
+Compare
IMCR
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$32.02
Change
-$0.00 (-0.00%)
Capitalization
1.57B

IMCR Immunocore Holdings plc Forecast, Technical & Fundamental Analysis

Immunocore Holdings PLC is a commercial-stage biotechnology company... Show more

IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IMCR with price predictions
Jun 27, 2025

IMCR sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for IMCR moved above the 200-day moving average on June 17, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

IMCR moved above its 50-day moving average on June 24, 2025 date and that indicates a change from a downward trend to an upward trend.

The Aroon Indicator entered an Uptrend today. In of 176 cases where IMCR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for IMCR moved out of overbought territory on June 06, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on June 13, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IMCR as a result. In of 67 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for IMCR turned negative on June 12, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IMCR broke above its upper Bollinger Band on May 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.131) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). IMCR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (4.713) is also within normal values, averaging (252.247).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IMCR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IMCR is expected to report earnings to fall 301.80% to -20 cents per share on August 06

Immunocore Holdings plc IMCR Stock Earnings Reports
Q2'25
Est.
$-0.20
Q1'25
Beat
by $0.49
Q4'24
Missed
by $0.23
Q3'24
Beat
by $0.50
Q2'24
Beat
by $0.25
The last earnings report on May 07 showed earnings per share of 10 cents, beating the estimate of -38 cents. With 223.46K shares outstanding, the current market capitalization sits at 1.57B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
92 Park Drive
Phone
+44 1235438600
Employees
497
Web
https://www.immunocore.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCADX55.330.48
+0.88%
Fidelity Advisor International Discv C
MYIFX20.390.15
+0.74%
Monetta Young Investor Growth
BRIUX16.320.10
+0.62%
Baron Real Estate Income R6
CDOYX40.420.10
+0.25%
Columbia Dividend Opportunity Inst3
GWGIX18.240.03
+0.16%
AMG GW&K Small Mid Cap Core I

IMCR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IMCR has been loosely correlated with IDYA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if IMCR jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMCR
1D Price
Change %
IMCR100%
N/A
IDYA - IMCR
51%
Loosely correlated
-4.13%
NRIX - IMCR
50%
Loosely correlated
+0.17%
XENE - IMCR
48%
Loosely correlated
+0.62%
IMNM - IMCR
46%
Loosely correlated
-0.23%
CRNX - IMCR
46%
Loosely correlated
-0.10%
More